ASAnastasiya L. Sepp

Anastasiya L. Sepp

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anastasiya L. Sepp has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Probiotic Strain Hafnia Alvei HA4597 and Its Protein Extract Selectively Activate Membrane Digestive Enzymes of Intestinal Cells in Mice

    by Anastasiya L. Katargina, Lyudmila V. Gromova, Alexander S. Polozov, Nadezhda M. Grefner, Vasily A. Zolotarev, Julia V. Dmitrieva, Catherine A. Lukina, Elena A. Vershinina, Alexander N. Suvorov, Nina S. Pestereva, et al.

    Oral supplementation of the Hafnia alvei (H. alvei) HA4597 probiotic strain has been shown to reduce appetite, body weight and fat content in overweight humans and obese mice. However, it remains unknown if H. alvei may also influence the gut digestive function. Thus, in the present study, the structural parameters of the intestine and the activity of digestive enzymes of the brush border enterocytes were analyzed in mice after they received a suspension of live H. alvei bacteria or their total protein extract for 16 days. Using electron microscopy, bacteria resembling H. alvei were found on the surface of microvilli of colonic enterocytes of mice treated with H. alvei suspension. In the group receiving H. alvei protein, there was a trend toward an increase in the number of mucus-producing goblet cells on the villi of the jejunum, and in both groups receiving H. alvei preparations, the number of intraepithelial lymphocytes on the villi of the ileum increased (in the group receiving H. alvei protein, there was a tendency towards an increase; in the group receiving H. alvei suspension, there was a significant increase). Treatment with both H. alvei preparations led to an increased activity of alkaline phosphatase in the chyme of the duodenum and jejunum and also in the jejunal mucosa, correlating negatively with visceral body fat content. The use of both H. alvei preparations had no significant effect on the activity of glucoamylase, maltase and aminopeptidase N in the intestinal mucosa. Thus, the 16-day administration of H. alvei bacteria or their protein extract increases the protective properties of the intestine, including the mucous barrier. Moreover, increased activity of alkaline phosphatase, a fat absorption-limiting enzyme, may contribute to the known anti-obesity effects of H. alvei. Taken together, H. alvei preparations display beneficial effects on gut health.

  • Open Access

    Melanocortin Receptor Signaling Modulates Anti-Obesity and Glucose Tolerance Effects of Hafnia alvei 4597 Probiotic Strain in Mice

    by Vasiliy A. Zolotarev, Vladimir O. Murovets, Egor A. Sozontov, Anastasia L. Sepp, Ekaterina A. Lukina, Raisa P. Khropycheva, Benjamin Thomas, Sergueï O. Fetissov

    The present study aimed to elucidate whether the metabolic effects of the probiotic bacterium Hafnia alvei 4597 depend on melanocortin receptor (MCR) signaling. The response to a 3-week intragastric treatment with the H. alvei bacterial suspension or total protein extract was compared between genetically similar mouse sub-strains but with different MCR sensitivity: KK and KK.Cg-Ay/a (KK-Ay)—the latter overproducing Agouti protein. Treatment of KK mice with H. alvei protein extract stimulated energy expenditure and carbohydrate oxidation but reduced lipid oxidation, leptin level, pancreatic weight, and hypothalamic insulin and leptin receptor mRNA expression. Live bacteria in KK mice reduced food intake and stimulated hypothalamic mRNA expression of proopiomelanocortin, Agouti-related peptide, and insulin receptors. In the sub-strain KK-Ay, probiotics had no effect on the aforementioned metabolic parameters. H. alvei-based probiotics improved glucose tolerance and decreased body fat and liver glycogen in both mouse sub-strains. Activation of MC4R by H. alvei protein extract was revealed by in vitro study using β-arrestin recruitment. These findings confirm beneficial effects of the H. alvei bacteria and show that, for several parameters, the bacterial protein extract may be more effective than bacterial suspension. Differential responses to the treatment between the mouse sub-strains, particularly in energy metabolism, as well as in vitro data, indicate that the effects of H. alvei are mediated by MCR signaling.


  • Open Access

    Melanocortin Receptor Signaling Modulates Anti-Obesity and Hypoglycemic Effects of Hafnia alvei 4597 Probiotic Strain in Mice

    by Vasiliy A. Zolotarev, Vladimir O. Murovets, Egor A. Sozontov, Anastasia L. Sepp, Ekaterina A. Lukina, Raisa P. Khropycheva, Benjamin Thomas, Serguei O. Fetissov

    Objective. The present study aimed to elucidate if the metabolic effects of probiotic bacterium Hafnia alvei 4597 depend on the melanocortin receptors (MCRs) signaling. Methods. The response to a 3-week intragastric treatment with the H. alvei bacterial suspension or total protein extract was compared between genetically similar mouse sub-strains but with different sensitivity of MCRs, KK and KK.Cg-Ay/a (KK-Ay), the latter overproducing agouti protein. Results. Treatment of KK mice with H. alvei protein extract stimulated energy expenditure and carbohydrate oxidation but reduced lipid oxidation, leptin level, pancreatic weight, and hypothalamic insulin and leptin receptor mRNA expression. Live bacteria in KK mice reduced food intake and stimulated hypothalamic mRNA expression of proopiomelanocortin, agouti-related peptide, and insulin receptors. In the sub-strain KK-Ay, probiotics had no effect on the aforementioned metabolic parameters. H. alvei-based probiotics improved glucose tolerance and deceased body fat and liver glycogen in both mouse sub-strains. Activation of MC4R by H. alvei protein extract was revealed by in vitro study showing of β-arrestin recruitment. Conclusion. These findings confirm beneficial effects of the H. alvei bacteria and show that, for several parameters, the bacterial protein extract may be a more efficacious than bacterial suspension. Differential responses to the treatment between the mouse sub-strains, particularly in energy metabolism, as well as in vitro data, indicate that the effects of H. alvei are mediated by MCRs signaling.


  • Open Access

    Protein Extract of a Probiotic Strain of Hafnia alvei and Bacterial ClpB Protein Improve Glucose Tolerance in Mice

    by Vasiliy A. Zolotarev, Vladimir O. Murovets, Anastasiya L. Sepp, Egor A. Sozontov, Ekaterina A. Lukina, Raisa P. Khropycheva, Nina S. Pestereva, Irina S. Ivleva, Mouna El Mehdi, Emilie Lahaye, et al.

    A commercial strain of Hafnia alvei (H. alvei) 4597 bacteria was shown to reduce food intake and promote weight loss, effects possibly induced by the bacterial protein ClpB, an antigen-mimetic of the anorexigenic α-melanocyte-stimulating hormone. A decrease in the basal plasma glucose levels was also observed in overweight fasted humans and mice receiving H. alvei. However, it is not known whether H. alvei influences sweet taste preference and whether its protein extract or ClpB are sufficient to increase glucose tolerance; these are the objectives tested in the present study. C57BL/6J male mice were kept under standard diet and were gavaged daily for 17 days with a suspension of H. alvei (4.5 × 107 CFU/animal) or with H. alvei total protein extract (5 μg/animal) or saline as a control. Sweet taste preference was analyzed via a brief-access licking test with sucrose solution. Glucose tolerance tests (GTT) were performed after the intraperitoneal (IP) or intragastric (IG) glucose administration at the 9th and 15th days of gavage, respectively. The expression of regulatory peptides’ mRNA levels was assayed in the hypothalamus. In another experiment performed in non-treated C57BL/6J male mice, effects of acute IP administration of recombinant ClpB protein on glucose tolerance were studied by both IP- and IG-GTT. Mice treated with the H. alvei protein extract showed an improved glucose tolerance in IP-GTT but not in IG-GTT. Both groups treated with H. alvei bacteria or protein extract showed a reduction of pancreatic tissue weight but without significant changes to basal plasma insulin. No significant effects of H. alvei bacteria or its total protein extract administration were observed on the sweet taste preference, insulin tolerance and expression of regulatory peptides’ mRNA in the hypothalamus. Acute administration of ClpB in non-treated mice increased glucose tolerance during the IP-GTT but not the IG-GTT, and reduced basal plasma glucose levels. We conclude that both the H. alvei protein extract introduced orally and the ClpB protein administered via IP improve glucose tolerance probably by acting at the glucose postabsorptive level. Moreover, H. alvei probiotic does not seem to influence the sweet taste preference. These results justify future testing of both the H. alvei protein extract and ClpB protein in animal models of diabetes.


  • Open Access

    Gut Digestive Function and Microbiome after Correction of Experimental Dysbiosis in Rats by Indigenous Bifidobacteria

    by Lyudmila V. Gromova, Elena I. Ermolenko, Anastasiya L. Sepp, Yulia V. Dmitrieva, Anna S. Alekseeva, Nadezhda S. Lavrenova, Mariya P. Kotyleva, Tatyana A. Kramskaya, Alena B. Karaseva, Alexandr N. Suvorov, et al.

    In recent years, great interest has arisen in the use of autoprobiotics (indigenous bacteria isolated from the organism and introduced into the same organism after growing). This study aimed to evaluate the effects of indigenous bifidobacteria on intestinal microbiota and digestive enzymes in a rat model of antibiotic-associated dysbiosis. Our results showed that indigenous bifidobacteria (the Bf group) accelerate the disappearance of dyspeptic symptoms in rats and prevent an increase in chyme mass in the upper intestine compared to the group without autoprobiotics (the C1 group), but significantly increase the mass of chyme in the colon compared to the C1 group and the control group (healthy animals). In the Bf group in the gut microbiota, the content of opportunistic bacteria (Proteus spp., enteropathogenic Escherichia coli) decreased, and the content of some beneficial bacteria (Bifidobacterium spp., Dorea spp., Blautia spp., the genus Ruminococcus, Prevotella, Oscillospira) changed compared to the control group. Unlike the C1 group, in the Bf group there was no decrease in the specific activities of maltase and alkaline phosphatase in the mucosa of the upper intestine, but the specific activity of maltase was decreased in the colon chyme compared to the control and C1 groups. In the Bf group, the specific activity of aminopeptidase N was reduced in the duodenum mucosa and the colon chyme compared to the control group. We concluded that indigenous bifidobacteria can protect the microbiota and intestinal digestive enzymes in the intestine from disorders caused by dysbiosis; however, there may be impaired motor function of the colon.